T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein
- PMID: 2461306
- DOI: 10.1002/eji.1830181012
T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein
Abstract
The sequences of a set of 63 peptides of demonstrated T immunogenicity have been analyzed and compared with two different randomly generated sets of sequences. This study indicates a statistically significant tendency of T immunogenic peptides to be constituted of clusters of rare tetrapeptides, as evaluated from the available sequence data banks. This result has been used to locate potential T epitopes in the human immunodeficiency virus (HIV) gag protein. Four peptides corresponding to the best candidate T epitopes (chosen in regions of conserved sequence among different virus isolates) have been synthesized and found to be recognized by a HIV-1-specific, HLA-A2-restricted human cytotoxic T cell line.
Similar articles
-
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.Nature. 1988 Dec 1;336(6198):484-7. doi: 10.1038/336484a0. Nature. 1988. PMID: 2461519
-
Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.J Virol. 1999 Dec;73(12):10191-8. doi: 10.1128/JVI.73.12.10191-10198.1999. J Virol. 1999. PMID: 10559335 Free PMC article.
-
Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.Eur J Immunol. 2001 Jun;31(6):1747-56. doi: 10.1002/1521-4141(200106)31:6<1747::aid-immu1747>3.0.co;2-l. Eur J Immunol. 2001. PMID: 11385619
-
HLA class I binding regions of HIV-1 proteins.Crit Rev Immunol. 1992;12(1-2):1-16. Crit Rev Immunol. 1992. PMID: 1384546 Review.
-
CD4+ T cell epitopes in HIV-1 proteins.Chem Immunol. 1993;56:127-49. Chem Immunol. 1993. PMID: 7680866 Review. No abstract available.
Cited by
-
Major histocompatibility complex class I binding predictions as a tool in epitope discovery.Immunology. 2010 Jul;130(3):309-18. doi: 10.1111/j.1365-2567.2010.03300.x. Epub 2010 May 26. Immunology. 2010. PMID: 20518827 Free PMC article. Review.
-
A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production.Immunology. 1992 Nov;77(3):322-9. Immunology. 1992. PMID: 1282493 Free PMC article.
-
RNA-mediated transfer of cellular immunity to a synthetic env antigen of the human immunodeficiency virus (HIV-1).Mol Cell Biochem. 1991 Nov 13;108(1):1-8. doi: 10.1007/BF00239536. Mol Cell Biochem. 1991. PMID: 1722867
-
Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides.J Exp Med. 1990 Sep 1;172(3):889-99. doi: 10.1084/jem.172.3.889. J Exp Med. 1990. PMID: 2388036 Free PMC article.
-
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.Proc Natl Acad Sci U S A. 1990 Mar;87(6):2344-8. doi: 10.1073/pnas.87.6.2344. Proc Natl Acad Sci U S A. 1990. PMID: 1690429 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials